跳至主要内容
临床试验/RBR-8dp876
RBR-8dp876尚未招募未知

Epigenetic modulation by N-3 Polyunsaturated Fatty Acids and bioactive compounds (Silybum Marianum L) in Non-Alcoholic Fatty Liver Disease

niversidade Federal do Rio de Janeiro0 个研究点开始时间: 2017年9月19日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

入选标准

  • Be 19 years of age or older; diagnosis of NAFLD by abdominal ultrasonography, and liver biopsy in the last 24 months preceding the intervention

排除标准

  • Viral hepatitis; infectious fever or outbreaks; cancer with or without chemotherapy and radiotherapy; inflammatory diseases of the gastrointestinal tract; transplant, trauma, surgery or hospitalization in the last 30 days; use of steroids or non-steroidal anti-inflammatories or immunomodulatory agents or antibiotics; use of n-3 fatty acid supplement in the last 3 months prior to study; pregnancy and lactation; alcohol intake greater than 20g / day for women and 30g / day for men

研究者

发起方
niversidade Federal do Rio de Janeiro

相似试验

Effects of Omega 3 and Cardo Mariano on MiRNAs... | 临床试验